Manitex Capital Inc., a 10% Holder, acquired 1,613,482 Common Shares Class A on a direct ownership basis at a price of $0.500 through a prospectus or prospectus exempt offering on July 25th, 2019. The insider also acquired 1,613,482 Warrants with an exercise price of $0.600 for 36 months. This represents a $806,741 investment into the company's shares and an account share holdings change of 8.0%.
In addition, Helen Saviuk, a Senior Officer and 10% Holder, acquired 47,803 Common Shares Class A and 47,803 Warrants on a direct ownership basis. This represents a $23,902 investment into the company's shares and an account share holdings change of 1.9%.
Valeo Pharma is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.
Valeo Pharma Inc is a Canada-based specialty pharmaceutical company dedicated to the commercialization of prescription products in Canada. With a focus on neurodegenerative diseases, woman's health, and oncology and supportive care, the Company has a portfolio of products and a platform to manage these products through stages of commercialization.
No Comments